People
Citius Pharmaceuticals appoints Dr John Laffey to ARDS Scientific Advisory Board
16 June 2021 -

Citius Pharmaceuticals Inc (Nasdaq: CTXR), a US-based biopharmaceutical company, announced on Tuesday that it has appointed Dr John Laffey to its ARDS Scientific Advisory Board, effective immediately.

Dr Laffey is serving as a professor of Anaesthesia and Intensive Care Medicine at the School of Medicine of the National University of Ireland and a Consultant in Anaesthesia and Intensive Care Medicine at Galway University Hospitals. He holds the position of a director of Clinical Research at Saolta Hospital Group and NUI Galway. He is also a principal investigator at the National Centre for Biomedical Engineering Sciences, and a clinical trials investigator at the HRB Clinical Research Facility at NUI Galway.

Also, Dr Laffey has served as principal investigator or co-principal investigator in multiple clinical trials in the fields of anaesthesia and critical illness.

Myron Holubiak, Citius Pharmaceuticals president and chief executive officer, was quoted as saying: "We are delighted to welcome John to our distinguished ARDS Scientific Advisory Board and look forward to leveraging his deep insights and decades of hands-on experience with ARDS to advance our proprietary i-MSC program."

Login
Username:

Password: